Neogen stock had its Relative Strength (RS) Rating upgraded from 80 to 86 Wednesday.
When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength.
This exclusive rating from Investor's Business Daily tracks share price movement with a 1 (worst) to 99 (best) score. The score shows how a stock's price performance over the last 52 weeks compares to all the other stocks in our database.
Over 100 years of market history shows that the best stocks often have an RS Rating north of 80 as they begin their biggest runs.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Neogen Stock A Buy?
Neogen stock is working on a cup without handle with a 21.61 buy point. See if it can clear the breakout price in heavy trade.
While revenue growth fell last quarter from 76% to 70%, earnings-per-share grew -20%, up from -21% in the prior report. The next quarterly numbers are expected on or around Jul. 18.
Neogen stock holds the No. 20 rank among its peers in the Medical-Products industry group. Lantheus Holdings and Penumbra are also among the group's highest-rated stocks.
